发明名称 |
Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers |
摘要 |
<p>Modified glucagon peptides are disclosed having improved solubility and/or half-life while retaining glucagon agonist activity. The glycogen peptides have been modified by substitution of native amino acids with, and/or addition of, charged amino acids to the carboxy terminus of the peptide. The modified glucagon agonists can be further modified by pegylation, or the addition of a carboxy terminal peptide selected from the group consisting of SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 23, or both to further enhance the solubility of the glucagon agonist analogs.</p> |
申请公布号 |
AU2009260301(B2) |
申请公布日期 |
2015.09.03 |
申请号 |
AU20090260301 |
申请日期 |
2009.06.16 |
申请人 |
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION |
发明人 |
SMILEY, DAVID L.;CHABENNE, JOSEPH;DIMARCHI, MARIA;DIMARCHI, RICHARD D.;DAY, JONATHAN |
分类号 |
A61K38/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|